Donehower, Ross C.

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine

Cancer Immunotherapy and BiomarkersGenetic factors in colorectal cancer

Cited by 9,377

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 6,645

Paclitaxel (Taxol)

Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine

Cancer Treatment and PharmacologyMicrotubule and mitosis dynamics

Cited by 1,924

A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer

Dees, E. C., O'reilly, S., Goodman, S. N., Sartorius, S., Levine, M. A., Jones, R. J., Grochow, L. B., Donehower, R. C., & Fetting, J. H. (2000) · Cancer Investigation

Breast Cancer Treatment StudiesCancer Treatment and Pharmacology

Cited by 180